[CORONA VIRUS, BREASTFEEDING AND GUIDELINES - A WORLDWIDE REVIEW].


Journal

Harefuah
ISSN: 0017-7768
Titre abrégé: Harefuah
Pays: Israel
ID NLM: 0034351

Informations de publication

Date de publication:
May 2021
Historique:
entrez: 24 5 2021
pubmed: 25 5 2021
medline: 28 5 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has forced countries worldwide to face major issues and challenges. Among those challenges is breastfeeding from the first hours after birth until late infancy, in hospitals and communities. There is a consensus throughout the world and among leading international professional medical associations that breastfeeding is of significant importance for short- and long-term health outcomes in mothers and infants, as well as for its public health impact and reduction of national health expenditures. Moreover, breastfeeding or human milk feeding have been shown to reduce morbidity, specifically respiratory infections, among infants and children. This is not the first time health systems are dealing with coronavirus outbreaks, although currently, in the COVID-19 pandemic, there is still much that is unknown. Dealing with the unknown can lead to guidelines that may not fully take into consideration relevant risk benefit ratios for individuals and groups. In this review, we aim to summarize the guidelines of different leading professional groups around the world dealing with the COVID-19 pandemic. Evidence-based medicine rests on relevant scientific evidence, patients' values and preferences and clinical judgment. We wish to propose guidelines based on available evidence concerning breastfeeding, the current pandemic and weighing in potential risks and benefits while highlighting the need for ongoing breastfeeding research.

Identifiants

pubmed: 34028218

Types de publication

Journal Article Review

Langues

heb

Sous-ensembles de citation

IM

Pagination

279-284

Auteurs

Moran Friedman (M)

CLALIT Health Services, Haifa and Western Galilee District, Israel.
Department of Family Medicine in Haifa, Israel.

Noa Gur Arieh (N)

Department of Family Medicine, Rabin Medical Center, Tel-Aviv, Dan, Petah-Tikva and Eilat districts, Clalit Health Services, Israel.

Ady Orbach (A)

Cardiology Department, Rambam Health Care Campus.

Nadav Haddad (N)

The Joyce.
Irving Goldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel.

Eloise Haddad (E)

Dvora Omer, Elementary School, Natanya, Israel.

Deena Rachel Zimmerman (DR)

Maternal Child and Adolescent Department, Public Health Service, Ministry of Health, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH